Scientific Leadership

Global Virus Network (GVN) Leaders Publish STAT Op-Ed with a U.S. Government Call to Action and Road Map for the Future of COVID-19

Retrieved on: 
星期二, 一月 31, 2023
University, MPH, Global Virus Network, Plan, COVID, SARS-CoV-2, University of Maryland, Baltimore, International Partnership on Avian and Pandemic Influenza, Centers for Disease Control and Prevention, Human, Entrepreneurship, CDC, Virology, Foreign policy of the Joe Biden administration, Associate, Center of excellence, USF, Internal medicine, Network affiliate, Institute of Human Virology Nigeria, Politics, Scientific Leadership, Innovation, GVN, COVID-19, Policy, Infection, Probability, Public, University of Maryland School of Medicine, Animal, Risk, Maryland School, Disease, Division, Administration, Doctor of Philosophy, Vaccine, Management, MD, Medicine, Science

This challenges the Biden Administration's COVID Winter Preparedness Plan and the Centers for Disease Control and Prevention's (CDC) recommendation of some exposure-avoidance for everyone.

Key Points: 
  • This challenges the Biden Administration's COVID Winter Preparedness Plan and the Centers for Disease Control and Prevention's (CDC) recommendation of some exposure-avoidance for everyone.
  • "Science is telling us that, for most people who aren't at high risk, COVID-19 is becoming a common airborne illness of manageable severity.
  • Early in his term, President Biden appointed his slate of science advisers with the promise that they would lead with 'science and truth.
  • '  They now have the opportunity to demonstrate that sound science and good politics can go hand in hand."

Evolution Research Group, LLC Establishes Internal Continuing Medical Education (CME) Program - Partners with University of Miami, Miller School of Medicine

Retrieved on: 
星期三, 十一月 16, 2022
Crus, CRO, MD, Licensure, Anesthesiology, Scientific Leadership, Knowledge, Chronic pain, NEW, Physician, Volunteering, SLT, University, Industry, View, Multimedia, Program, ERG, Patient, Principal, CME, Division, Neuroscience, LLC, Drug, Psychiatry, Continuing medical education, Sleep, Pharmaceutical industry

The development of this program was derived from ERG's Scientific Leadership team (SLT).

Key Points: 
  • The development of this program was derived from ERG's Scientific Leadership team (SLT).
  • The SLT is comprised of internal and external industry experts across all therapeutic areas in which the organization focuses.
  • "In today's busy research environment, physician Investigators and clinicians are hard pressed to find the time to meet licensure requirements for continuing education.
  • Evolution Research Group, LLC is a subsidiary of ERG Holding Company, which includes twenty owned and operated CRUs,an established network of affiliated clinical research sites, Lotus Clinical Research, LLC, a full-service CRO, and CNS Ratings, LLC.

Aziyo Biologics Co-Founder and Regenerative Medicine Pioneer, Dr. Randy Mills, appointed Chief Executive Officer

Retrieved on: 
星期二, 八月 9, 2022
People, Woman, Regeneration, U.S. Securities and Exchange Commission, Sustainability Accounting Standards Board, CEO, GLOBE, R, Forward-looking statement, Private Securities Litigation Reform Act, Regenerative medicine, Board, Medicine, Security (finance), Ernst & Young Entrepreneur of the Year Award, AATB, Patient, Therapy, Bone marrow, Company, Scientific Leadership, Skin, Biotechnology, Infection, Smith, World, Organization, Goal, Investor, National Marrow Donor Program, IPO, Osiris Therapeutics, California Institute for Regenerative Medicine, Heart block, Management, Pharmaceutical industry, Osiris, Transplant

SILVER SPRING, Md., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced that Aziyo co-founder C. Randal (Randy) Mills, Ph.D. has assumed the President and Chief Executive Officer role on an on-going basis.

Key Points: 
  • SILVER SPRING, Md., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced that Aziyo co-founder C. Randal (Randy) Mills, Ph.D. has assumed the President and Chief Executive Officer role on an on-going basis.
  • Since creating Aziyo in 2015, Randy and I have worked together to build a company where regenerative medicine is used to its full potential, said Kevin Rakin, co-founder and executive chairman.
  • Randy is a visionary leader with a track record of creating significant shareholder value in regenerative medicine.
  • The Board and I look forward to partnering with Randy as we make his vision for this company a reality.